REVELATION BIOSCIENCES INC

Revelation Biosciences Stock Falls 3% as 200‑Day SMA Nears $9.11

Revelation Biosciences shares dip to $3.75 amid 52‑week lows, reflecting a volatile clinical‑stage biopharma market and recent regulatory milestones.

REVELATION BIOSCIENCES INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Jake Connors

21/10/2026, 09:06

2 minutes to read

Revelation Biosciences (REVB) Slides 3.18% to $3.45 Amid 52‑Week Dip

Revelation Biosciences shares fell 3.18 % to $3.45 as investors weigh its viral‑disease pipeline and market volatility—learn what drives its 51.93 % monthly decline.

REVELATION BIOSCIENCES INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Jake Connors

20/10/2026, 21:11

2 minutes to read